Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation

References

• Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, et al. Isolation and characterization of binding proteins for advanced glycosylation end products from lung tissue which are present on the endothelial cell surface. J Biol Chem. 1992; 267: 14987–97
   PubMed Web of Science ®Google Scholar
• Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen M, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem. 1995; 270: 25752–61
   PubMed Web of Science ®Google Scholar
• Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999; 97: 889–901
   PubMed Web of Science ®Google Scholar
• Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 1996; 382: 685–91
   PubMed Web of Science ®Google Scholar
• Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med. 2003; 198: 1507–15
   PubMed Web of Science ®Google Scholar
• Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, Hammami MM, et al. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol. 2002; 71: 433–44
   PubMed Web of Science ®Google Scholar
• Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Yan SD, et al. N-ε (carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signalling pathways and modulate gene expression. J Biol Chem. 1999; 274: 31740–9
   PubMed Web of Science ®Google Scholar
• Toure F, Zahm JM, Garnotel R, Lambert E, Bonnet N, Schmidt AM, et al. Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated matrix. Biochem J. 2008; 416: 255–61
   PubMed Web of Science ®Google Scholar
• Zen K, Chen CX, Chen YT, Wilton R, Liu Y. Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J Immunol. 2007; 178: 2483–90
   PubMed Web of Science ®Google Scholar
• Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, et al. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1 integrin. EMBO J. 2007; 26: 1129–39
   PubMed Web of Science ®Google Scholar
• Yan SD, Schmidt AM, Anderson G, Zhang J, Brett J, Zou YS, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994; 269: 9889–97
   PubMed Web of Science ®Google Scholar
• Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, et al. Expression of pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003; 42: 1383–9
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 2004; 50: 1286–95
   PubMed Web of Science ®Google Scholar
• Wittkowski H, Sturrock A, van Zoelen MA, Viermann D, van der Poll T, Hoidal JR, et al. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med. 2007; 35: 1369–75
   PubMed Web of Science ®Google Scholar
• Foell D, Seeliger S, Vogl T, Koch HG, Maschek H, Harms E, et al. Expression of S100A12 in cystic fibrosis. Thorax. 2003; 58: 613–7
   PubMed Web of Science ®Google Scholar
• Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut. 2003; 52: 847–53
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest. 1993; 91: 2155–68
   PubMed Web of Science ®Google Scholar
• Miyata T, Hori O, Zhang J, Yan SD, Ferran L, Iida Y, et al. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest. 1996; 98: 1088–94
   PubMed Web of Science ®Google Scholar
• Rouhiainen A, Kuja-Panula J, Wilkman E, Pakkanen J, Stenfors J, Tuominen RK, et al. Regulation of monocyte migration by amphoterin. Blood. 2004; 104: 1174–82
   PubMed Web of Science ®Google Scholar
• Hou FF, Miyata T, Boyce J, Yuan Q, Chertow GM, Kay J, et al. beta[2] Microglobulin modified with advanced glycation end-products delays monocyte apoptosis. Kidney Int. 2001; 59: 990–1002
   Google Scholar
• Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab. 2001; 280: E685–94
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002; 418: 191–5
   PubMed Web of Science ®Google Scholar
• Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, et al. High mobility group box 1 protein interacts with multiple toll-like receptors. Am J Physiol Cell Physiol. 2006; 290: C917–24
   PubMed Web of Science ®Google Scholar
• Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Toll-like receptor-9 dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007; 8: 487–96
   PubMed Web of Science ®Google Scholar
• Zamora R, Grishin A, Wong C, Boyle P, Wang J, Hackam D, et al. High mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod. Am J Physiol Gastrointest Liver Physiol. 2005; 289: G643–52
   Google Scholar
• Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, et al. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol. 2001; 171: 29–45
   PubMed Web of Science ®Google Scholar
• Walker DG, Link J, Lue LF, Dalsing-Hernandez JE, Boyes BE. Gene expression changes by amyloid beta peptide stimulated human postmortem brain microglia identify activation of multiple inflammatory processes. J Leukoc Biol. 2006; 79: 596–610
   Google Scholar
• Ichikawa K, Yoshinari M, Iwase M, Wakisaka M, Doi Y, Iino K, et al. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis. 1998; 136: 281–7
   Google Scholar
• Ding Y, Kantarci A, Badwey JA, Hasturk H, Malabanan A, Van Dyke TE. Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol. 2007; 179: 647–54
   PubMed Web of Science ®Google Scholar
• Yan SSD, Wu ZY, Zhang HP, Furtado G, Chen X, Yan SF, et al. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nat Med. 2003; 9: 287–93
   PubMed Web of Science ®Google Scholar
• Chen Y, Yan SS, Colgan J, Zhang HP, Luban J, Schmidt AM, et al. Blockade of the late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J Immunol. 2004; 173: 1399–405
   PubMed Web of Science ®Google Scholar
• Moser B, Szabolcs MJ, Ankersmit HJ, Lu Y, Qu W, Weinberg A, et al. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am J Transplant. 2007; 7: 293–302
   PubMed Web of Science ®Google Scholar
• Moser B, Desai DD, Downie MP, Chen Y, Yan SF, Herold K, et al. Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. J Immunol. 2007; 179: 8051–8
   PubMed Web of Science ®Google Scholar
• Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP, et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol. 2005; 174: 7506–15
   PubMed Web of Science ®Google Scholar
• Dumitriu IE, Baruah P, Bianchi ME, Manfredi AA, Rovere-Querini P. Requirement of HMGB1 and RAGE for the maturation of plasmacytoid dendritic cells. Eur J Immunol. 2005; 35: 2184–90
   PubMed Web of Science ®Google Scholar
• Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol. 2007; 81: 59–66
   PubMed Web of Science ®Google Scholar
• Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol. 2007; 81: 84–91
   PubMed Web of Science ®Google Scholar
• Manfredi AA, Capobianco A, Esposito A, De Cobelli F, Canu T, Monno A, et al. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol. 2008; 180: 2270–5
   PubMed Web of Science ®Google Scholar
• Cataldegirmen G, Zeng S, Feirt N, Ippagunta N, Dun H, Qu W, et al. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kB. J Exp Med. 2005; 201: 473–84
   PubMed Web of Science ®Google Scholar
• Andrassy M, Igwe J, Autschbach F, Volz C, Remppis A, Neurath MF, et al. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am J Path. 2006; 169: 1223–37
   Google Scholar
• Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, et al. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis. 2008; 29: 2035–43
   PubMed Web of Science ®Google Scholar
• Maeda S, Hikiba Y, Shibata W, Ohmae T, Yanai A, Ogura K, et al. Essential roles of high mobility group box-1 in the development of murine colitis and colitis-associated cancer. Biochem Biophys Res Commun. 2007; 360: 394–400
   PubMed Web of Science ®Google Scholar
• Pisetsky DS, Erlandsson-Harris H, Andersson U. High mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther. 2008; 10: 209
   PubMed Web of Science ®Google Scholar
• Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, et al. RAGE and arthritis: the G82 polymorphism amplifies the inflammatory response. Genes Immun. 2002; 3: 123–35
   PubMed Web of Science ®Google Scholar
• Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004; 113: 1641–50
   PubMed Web of Science ®Google Scholar
• Lutterloh EC, Opal SM, Pittman DD, Keith JC, Jr, Tan XY, Clancy BM, et al. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit Care. 2007; 11: R122
   PubMed Web of Science ®Google Scholar
• Boyd JH, Kan B, Roberts H, Wang Y, Walley KR. S100A8 and S100A9 mediate endotoxin induced cardiomyocyte dysfunction via receptor for advanced glycation end products. Circ Res. 2008; 102: 1239–46
   PubMed Web of Science ®Google Scholar
• Bucciarelli LG, Kaneko M, Ananthakrishnan R, Harja E, Lee LK, Hwang YC, et al. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury. Circulation. 2006; 113: 1226–34
   PubMed Web of Science ®Google Scholar
• Bucciarelli LG, Ananthakrishnan R, Hwang YC, Kaneko Song F, Sell DR, et al. RAGE and modulation of ischemic injury in the diabetic myocardium. Diabetes. 2008; 57: 1941–51
   PubMed Web of Science ®Google Scholar
• Aleshin A, Ananthakrishnan R, Li Q, Rosario R, Lu Y, Qu W, et al. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model. Am J Physiol. 2008; 294: H1823–32
   Google Scholar
• Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, et al. High mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation. 2008; 117: 3216–26
   PubMed Web of Science ®Google Scholar
• Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong U, et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury in the liver in mice. Hepatology. 2004; 39: 422–32
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 1995; 96: 1395–403
   PubMed Web of Science ®Google Scholar
• Gao X, Zhang H, Schmidt AM, Zhang C. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol. 2008; 295: H491–8
   PubMed Web of Science ®Google Scholar
• Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ, Jr, Chow WS, et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med. 1998; 4: 1025–31
   PubMed Web of Science ®Google Scholar
• Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ, Jr, et al. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E null mice. Arterioscler Thromb Vasc Biol. 2001; 21: 905–10
   PubMed Web of Science ®Google Scholar
• Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E null mice. Circulation. 2002; 106: 2827–35
   PubMed Web of Science ®Google Scholar
• Wendt T, Harja E, Bucciarelli L, Qu W, Lu Y, Rong LL, et al. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis. 2006; 185: 70–7
   PubMed Web of Science ®Google Scholar
• Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes. 2008; 57: 2461–9
   PubMed Web of Science ®Google Scholar
• Harja E, Bu DX, Hudson BI, Chang JS, Shen X, Hallam K, et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in Apo E -/- mice. J Clin Invest. 2008; 118: 183–94
   PubMed Web of Science ®Google Scholar
• Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, et al. Blockade of amphoterin/RAGE signaling suppresses tumor growth and metastases. Nature. 2000; 405: 354–60
   PubMed Web of Science ®Google Scholar
• Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem. 1997; 272: 17810–4
   PubMed Web of Science ®Google Scholar
• Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, et al. Key role of Src kinase in S100b-induced activation of the receptor for advanced glycation end products in smooth muscle cells. J Biol Chem. 2006; 281: 13685–93
   PubMed Web of Science ®Google Scholar
• Sakaguchi T, Yan SF, Yan SD, Rong LL, Sousa M, Belov D, et al. Arterial restenosis: central role of RAGE-dependent neointimal expansion. J Clin Invest. 2003; 111: 959–72
   PubMed Web of Science ®Google Scholar
• Bianchi R, Adami C, Giamanco I, Donato R. S100b binding to RAGE in microglia stimulates cox-2 expression. J Leukocy Biol. 2007; 81: 108–18
   PubMed Web of Science ®Google Scholar
• Huttunen H.J, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE) mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem. 1999; 274: 19919–24
   PubMed Web of Science ®Google Scholar
• Chang JS, Wendt T, Qu W, Kong L, Zou YS, Schmidt AM, et al. Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circ Res. 2008; 102: 905–13
   PubMed Web of Science ®Google Scholar
• Bellas R.E, FitzGerald M.J, Fausto N, Sonenshein G.E. Inhibition of NF-kB activity induces apoptosis in murine hepatocytes. Am J Pathol. 1997; 151: 891–6
   PubMed Web of Science ®Google Scholar
• Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol. 2001; 159: 513–25
   PubMed Web of Science ®Google Scholar
• Rong LL, Trojaborg W, Qu W, Kostov K, Yan SD, Gooch C, et al. Antagonism of RAGE suppresses peripheral nerve regeneration. FASEB J. 2004; 18: 1812–7
   Google Scholar
• Rong LL, Yan SF, Wendt T, Hans D, Pachydaki S, Bucciarelli LG, et al. RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. FASEB J. 2004; 18: 1818–25
   Google Scholar
• Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest. 2004; 114: 1741–51
   PubMed Web of Science ®Google Scholar
• Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, et al. Receptor for advanced glycation end products (RAGE) and experimental diabetic neuropathy. Diabetes. 2008; 57: 1002–17
   PubMed Web of Science ®Google Scholar
• Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G, et al. Exogenous high mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res. 2005; 97: e73–83
   PubMed Web of Science ®Google Scholar
• Kitahara T, Takeishi Y, Harada M, Nizeki T, Suzuki S, Sasaki T, et al. High mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res. 2008; 80: 40–6
   PubMed Web of Science ®Google Scholar
• Guo XH, Huang QB, Chen B, Wang SY, Li Q, Zhu YJ, et al. Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells. APMIS. 2006; 114: 874–83
   Google Scholar
• Hsieh HL, Schafer BW, Weigle B, Heizmann CW. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem Biophys Res Commun. 2004; 316: 949–59
   PubMed Web of Science ®Google Scholar
• Kaji Y, Amano S, Usui T, Oshika T, Yamashiro K, Ishida S, et al. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci. 2003; 44: 521–8
   PubMedGoogle Scholar
• Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003; 101: 2652–60
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia. 1998; 41: 1435–41
   PubMed Web of Science ®Google Scholar
• Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, Kim KS, et al. Human blood brain barrier receptors for Alzheimer's amyloid-beta 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest. 1998; 102: 734–43
   Google Scholar
• Bierhaus A, Illmer T, Kasper M, Luther T, Quehenberger P, Tritschler H, et al. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation. 1997; 96: 2262–71
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Hasu M, Popov D, Zhang JH, Chen J, Yan SD, et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci U S A. 1994; 91: 8807–11
   PubMed Web of Science ®Google Scholar
• Wautier JL, Wautier MP, Schmidt AM, Anderson GM, Hori O, Zoukourian C, et al. AGEs on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci U S A. 1994; 91: 7742–6
   PubMed Web of Science ®Google Scholar
• Warboys, CM, Toh, HB, Fraser, P. AGEs rapidly increase retinal microvascular permeability via RAGE activation of NADPH oxidase. Invest Ophthalmol Vis Sci. Nov 7, 2008, (Epub ahead of print).
   Google Scholar
• Shaw SS, Schmidt AM, Banes AK, Wang X, Stern DM, Marrero MB. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes. 2003; 52: 2381–8
   PubMed Web of Science ®Google Scholar
• Yoon YW, Kang TS, Lee BK, Chang W, Hwang KC, Rhee JH. Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med. 2008; 40: 398–406
   PubMed Web of Science ®Google Scholar
• Korenaga K, Micci MA, Taglialatela G, Pastricha PJ. Suppression of nNOS expression in rat enteric neurones by the receptor for advanced glycation end-products. Neurogastroenterol Motil. 2006; 18: 392–400
   Google Scholar
• Wang L, Li S, Jungalwala FB. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth. J Neurosci Res. 2008; 86: 1254–66
   Google Scholar
• Origlia N, Righi M, Capsoni S, Cattaneo A, Fang F, Stern DM, et al. Receptor for advanced glycation end product-dependent activation of p38 mitogen activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction. J Neurosci. 2008; 28: 3521–30
   PubMed Web of Science ®Google Scholar
• Hassid BG, Nair MN, Ducruet AF, Otten ML, Komotar RJ, Pinsky DJ, et al. Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemia. J Clin Neurosci. 2008; 16: 302–6
   Google Scholar
• Kobayashi T, Oku H, Komori A, Okuno T, Kojima S, Obayashi H, et al. Advanced glycation end products induce death of retinal neurons via activation of nitric oxide synthase. Exp Eye Res. 2005; 81: 647–54
   PubMed Web of Science ®Google Scholar
• Arancio O, Zhang HP, Chen X, Lin C, Trinchese F, Puzzo D, et al. RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J. 2004; 23: 4096–105
   PubMed Web of Science ®Google Scholar
• Kogel D, Peters M, Konig HG, Hashemi SM, Bui NT, Arolt V, et al. S100b potently activates p65-c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury. Neuroscience. 2004; 127: 913–20
   PubMed Web of Science ®Google Scholar
• Srikrishna G, Huttunen HJ, Johansson L, Weigle B, Yamaguchi Y, Rauvala H, et al. N-glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J Neurochem. 2002; 80: 998–1008
   PubMed Web of Science ®Google Scholar
• Huttunen HJ, Kuja-Panula J, Rauvala H. RAGE signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem. 2002; 277: 38635–46
   PubMedGoogle Scholar
• Du Yan S, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW, et al. Amyloid beta peptide receptor for advanced glycation endproduct interaction elicitis neuronal expression of macrophage colony stimulating factor: a proinflammatory pathway in Alzheimer's disease. Proc Natl Acad Sci U S A. 1997; 94: 5296–301
   PubMed Web of Science ®Google Scholar
• Sousa MM, Yan SD, Stern D, Saraiva MJ. Interaction of RAGE with transthyretin triggers nuclear transcription factor (NF-kB) activation. Lab Invest. 2000; 80: 1101–10
   PubMed Web of Science ®Google Scholar
• Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J Biol Chem. 2000; 275: 40096–105
   PubMed Web of Science ®Google Scholar
• Sousa MM, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva MJ. Familial amyloid polyneuropathy: RAGE dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci. 2001; 21: 7576–86
   PubMed Web of Science ®Google Scholar